[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.65.227. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Quick Uptakes
December 23/30, 1998

. . . and Encouraging Compliance

Author Affiliations
 

Not Available

Not Available

JAMA. 1998;280(24):2067. doi:10.1001/jama.280.24.2067-JQU80009-3-1

Patients recently diagnosed as having HIV infection go through a dual trauma: coming to terms with the diagnosis itself and then learning that their lives will be governed by a strict regimen of medications, many with difficult adverse effects.

"Adherence is crucial to the success of anti-HIV drugs," noted Lori Esch, PharmD, assistant professor of pharmacy practice at the State University of New York at Buffalo School of Pharmacy. During last month's meeting of the American College of Clinical Pharmacists in Cincinnati, Esch described the novel HIV Medication Adherence Clinic that she and her colleagues established last year at the Erie County Medical Center in Buffalo. "The purpose of our clinic is to try to spend time with the patient before he or she even starts [the] medication," she said.

First Page Preview View Large
First page PDF preview
First page PDF preview
×